Clinical trials
Completed Phase 3 Sjogren's Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Allergan | 1 |
| Amgen | 1 |
| Cairo University | 1 |
| Instituto de Oftalmología Fundación Conde de Valenciana | 1 |
| Novartis Pharmaceuticals | 1 |
| Pavly Moawd | 1 |
| Seoul National University Hospital | 1 |
| Sylentis, S.A. | 1 |
| Universidad Nacional de Colombia | 1 |
| University Medical Center Groningen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sjogren's Syndrome | 10 |
| Dry Eye Syndromes | 6 |
| Autoimmune Diseases | 2 |
| Keratoconjunctivitis Sicca | 2 |
| Arthritis, Rheumatoid | 1 |
| Insulin Resistance | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Myositis | 1 |
| Scleroderma, Diffuse | 1 |
| Scleroderma, Systemic | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.